Immediate Impact
1 by Nobel laureates 3 from Science/Nature 69 standout
Citing Papers
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer
2024 Standout
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2024 Standout
Works of Samuel Suzuki being referenced
Ganitumab with either exemestane or fulvestrant for postmenopausal women with advanced, hormone-receptor-positive breast cancer: a randomised, controlled, double-blind, phase 2 trial
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Samuel Suzuki | 222 | 123 | 46 | 205 | 22 | 439 | |
| Hiroyuki Maeta | 143 | 77 | 20 | 190 | 24 | 408 | |
| Joan Morote | 114 | 194 | 18 | 173 | 22 | 483 | |
| Weijun Tian | 119 | 70 | 49 | 135 | 24 | 402 | |
| Wei Liu | 109 | 52 | 10 | 113 | 24 | 398 | |
| Eric de Kant | 152 | 68 | 28 | 272 | 18 | 417 | |
| S. C. Remick | 232 | 74 | 24 | 139 | 25 | 398 | |
| M.C. Cox | 173 | 169 | 29 | 89 | 23 | 409 | |
| Carrie B. Marshall | 134 | 126 | 17 | 92 | 20 | 379 | |
| Noëlla Blétard | 101 | 43 | 78 | 124 | 25 | 407 | |
| Greg Friberg | 188 | 116 | 14 | 258 | 15 | 487 |
All Works
Loading papers...